A new drug, donanemab, is being hailed as a turning point in the fight against Alzheimer’s, after a global trial confirms it slows cognitive decline. The...
Health care
The WHO European Region achieved 94% average coverage with 3 doses of the diphtheria, tetanus and pertussis vaccine (DTP3) and 93% average coverage with the...
TALAMANCA, Costa Rica/UNITED NATIONS, New York – “When I’m working in the gynaecology area and I see an Afrodescendent person, I feel concerned. Because I know...
The present study, which was conducted by LymeDisease.org, a research and advocacy organization, assessed sex-based differences in Lyme disease patients who...
Key Industry Insights & Findings from the report: Minimal invasive technologies are designed to cause less trauma than traditional open surgeries, reduced...
